2 U.S. scientists win Nobel chemistry prize
STOCKHOLM — Americans Robert Lefkowitz and Brian Kobilka won the 2012 Nobel Prize in chemistry Wednesday for studies of protein receptors that let body cells sense and respond to outside signals. Such studies are key for developing better drugs.
The Royal Swedish Academy of Sciences said the two researchers had made groundbreaking discoveries, mainly in the 1980s, on an important family of receptors, known as G-protein-coupled receptors.
About half of all medications act on these receptors, so learning about them will help scientists to come up with better drugs.
The human body has about 1,000 kinds of such receptors, structures on the surface of cells, which let the body respond to a wide variety of chemical signals, like adrenaline. Some receptors are in the nose, tongue and eyes, and let us sense smells, tastes and light.
Lefkowitz, 69, is an investigator at the Howard Hughes Medical Institute and professor at Duke University Medical Center in Durham, North Carolina.
Kobilka, 57, is a professor at Stanford University School of Medicine in California.
Lefkowitz said he was fast asleep when the Nobel committee called, but he didn't hear it because he was wearing ear plugs. So his wife picked up the phone.
“She said, ‘There's a call here for you from Stockholm,'” Lefkowitz told The Associated Press. “I knew they ain't calling to find out what the weather is like in Durham today.”
He said he didn't have an “inkling” that he was being considered for the Nobel Prize.
“Initially, I expected I'd have this huge burst of excitement. But I didn't. I was comfortably numb,” Lefkowitz said.
Kobilka said he found out around 2:30 a.m., after the Nobel committee called his home twice. He said he didn't get to the phone the first time, but that when he picked up the second time, he spoke to five members of the committee.
“They passed the phone around and congratulated me,” Kobilka told AP. “I guess they do that so you actually believe them. When one person calls you, it can be a joke, but when five people with convincing Swedish accents call you, then it isn't a joke.”
He said he would put his half of the 8 million kronor ($1.2 million) award toward retirement or “pass it on to my kids.”
The academy said it was long a mystery how cells interact with their environment and adapt to new situations, such as when adrenaline acts on cells to increase blood pressure and make the heart beat faster.
Scientists suspected that cell surfaces had some type of receptor for hormones.
Using radioactivity, Lefkowitz managed to unveil receptors including the receptor for adrenaline, and started to understand how it works.
Kobilka's work in the 1980s helped researchers realize that there is a whole family of receptors that look alike — a family that is now called G-protein-coupled receptors.
In 2011, Kobilka achieved another breakthrough when his team captured an image of the receptor for adrenaline at the moment when it is activated by a hormone and sends a signal into the cell. The academy called the image “a molecular masterpiece.”
The award is “fantastic recognition for helping us further understand the intricate details of biochemical systems in our bodies,” said Bassam Z. Shakhashiri, president of the American Chemical Society.
“They both have made great contributions to our understanding of health and disease,” Shakhashiri said. “This is going to help us a great deal to develop new pharmaceuticals, new medicines for combating disease.”
Mark Downs, chief executive of Britain's Society of Biology, said the critical role receptors play is now taking for granted.
“This groundbreaking work spanning genetics and biochemistry has laid the basis for much of our understanding of modern pharmacology as well as how cells in different parts of living organisms can react differently to external stimulation, such as light and smell, or the internal systems which control our bodies such as hormones,” Downs said in a statement.
The U.S. has dominated the Nobel chemistry prize in recent years, with American scientists being included among the winners of 17 of the past 20 awards.
This year's Nobel announcements started Monday with the medicine prize going to stem cell pioneers John Gurdon of Britain and Japan's Shinya Yamanaka. Frenchman Serge Haroche and American David Wineland won the physics prize Tuesday for work on quantum particles.
The Nobel Prizes were established in the will of 19th century Swedish industrialist Alfred Nobel, the inventor of dynamite. The awards are always handed out on Dec. 10, the anniversary of Nobel's death in 1896.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Sestak kicks off U.S. Senate campaign — with a couple missteps
- Court rules Steelers must pay Okobi workers comp
- 11 Ligonier Township residents rescued by boat from floodwaters
- Elizabeth Township, McKeesport impacted by ice jam on Youghiogheny River
- Penguins need trade-deadline acquisitions to bring toughness
- PennDOT alerts drivers to numerous road closures due to flooding, debris
- Shania’s first tour in 11 years includes Pittsburgh stop
- Owner of Strip District nightclub Ivy agrees to close after shooting
- Police: Suspect in 1970 cold case homicide of 17-year-old dies days before charges filed
- Blue Jays’ Martin has ‘nothing but praise’ for former Pirates teammates
- U.S. clears police officer in Ferguson case, criticizes police force